<DOC>
	<DOCNO>NCT01568736</DOCNO>
	<brief_summary>The hyper IgD syndrome ( HIDS ) inflammatory disease cause mevalonate kinase deficiency . There cure , available treatment HIDS febrile episode show limited clinical efficacy . The development effective intervention HIDS limit poor understanding disease . The goal study well characterize inflammatory response HIDS episodes determine relationship response blood urine marker mevalonate kinase deficiency . This knowledge help u learn cause disease lead identification new disease biomarkers use evaluate clinical efficacy future therapeutic trial . The primary hypothesis costimulatory B7 glycoprotein abnormality identify murine MKD model recapitulate serum obtain human HIDS patient , either , febrile episode . The secondary hypothesis B7 glycoprotein molecule level correlate clinical symptomatic severity score , know biomarkers HIDS , marker inflammation marker isoprenoid metabolism .</brief_summary>
	<brief_title>B7 Coreceptor Molecules Hyper IgD Syndrome Form Mevalonate Kinase Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Mevalonate Kinase Deficiency</mesh_term>
	<criteria>race ethnicity diagnose HIDS parent ' inability donate blood currently cancer , renal failure , diabetes , liver disease , thyroid disease , major infectious disease immunodeficiency pregnancy inability provide consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Hyper IgD Syndrome ( HIDS )</keyword>
	<keyword>Mevalonate Kinase Deficiency ( MKD )</keyword>
</DOC>